Pharma Equity Group A/S
CSE:PEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Melcor Real Estate Investment Trust
TSX:MR.UN
|
CA |
|
Canggang Railway Ltd
HKEX:2169
|
CN |
|
D
|
Dong In Entech Co Ltd
KRX:111380
|
KR |
|
A
|
Aeon Hokkaido Corp
TSE:7512
|
JP |
|
Mutual Corp
TSE:2773
|
JP |
|
Hepion Pharmaceuticals Inc
NASDAQ:HEPA
|
US |
|
Polyrocks Chemical Co Ltd
SSE:688669
|
CN |
|
Whirlpool of India Ltd
BSE:500238
|
IN |
|
Dermapharm Holding SE
XETRA:DMP
|
DE |
|
Yanbu Cement Company SJSC
SAU:3060
|
SA |
|
A
|
Access Group Holdings Co Ltd
TSE:7042
|
JP |
|
Dexco SA
BOVESPA:DXCO3
|
BR |
|
Srestha Finvest Ltd
BSE:539217
|
IN |
|
Hagihara Industries Inc
TSE:7856
|
JP |
Pharma Equity Group A/S
Other Equity
Pharma Equity Group A/S
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharma Equity Group A/S
CSE:PEG
|
Other Equity
-kr97.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jeudan A/S
CSE:JDAN
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Copenhagen Capital A/S
CSE:CPHCAP ST
|
Other Equity
-kr1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Prime Office A/S
CSE:PRIMOF
|
Other Equity
kr47.6m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fast Ejendom Danmark A/S
CSE:FED
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
E
|
EgnsINVEST Ejendomme Tyskland A/S
CSE:EGNETY
|
Other Equity
-kr4.8m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-72%
|
CAGR 10-Years
N/A
|
|
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.
See Also
What is Pharma Equity Group A/S's Other Equity?
Other Equity
-97.3m
DKK
Based on the financial report for Dec 31, 2025, Pharma Equity Group A/S's Other Equity amounts to -97.3m DKK.
What is Pharma Equity Group A/S's Other Equity growth rate?
Other Equity CAGR 1Y
-8%
Over the last year, the Other Equity growth was -8%.
